Literature DB >> 32115405

The transcription factor Sp1 modulates RNA polymerase III gene transcription by controlling BRF1 and GTF3C2 expression in human cells.

Feixia Peng1, Ying Zhou1, Juan Wang1, Baoqiang Guo2, Yun Wei1, Huan Deng1, Zihui Wu1, Cheng Zhang1, Kaituo Shi1, Yuan Li1, Xin Wang3, Paul Shore4, Shasha Zhao5, Wensheng Deng6.   

Abstract

Specificity protein 1 (Sp1) is an important transcription factor implicated in numerous cellular processes. However, whether Sp1 is involved in the regulation of RNA polymerase III (Pol III)-directed gene transcription in human cells remains unknown. Here, we first show that filamin A (FLNA) represses Sp1 expression as well as expression of TFIIB-related factor 1 (BRF1) and general transcription factor III C subunit 2 (GTF3C2) in HeLa, 293T, and SaOS2 cell lines stably expressing FLNA-silencing shRNAs. Both BRF1 promoter 4 (BRF1P4) and GTF3C2 promoter 2 (GTF3C2P2) contain putative Sp1-binding sites, suggesting that Sp1 affects Pol III gene transcription by regulating BRF1 and GTF3C2 expression. We demonstrate that Sp1 knockdown inhibits Pol III gene transcription, BRF1 and GTF3C2 expression, and the proliferation of 293T and HeLa cells, whereas Sp1 overexpression enhances these activities. We obtained a comparable result in a cell line in which both FLNA and Sp1 were depleted. These results indicate that Sp1 is involved in the regulation of Pol III gene transcription independently of FLNA expression. Reporter gene assays showed that alteration of Sp1 expression affects BRF1P4 and GTF3C2P2 activation, suggesting that Sp1 modulates Pol III-mediated gene transcription by controlling BRF1 and GTF3C2 gene expression. Further analysis revealed that Sp1 interacts with and thereby promotes the occupancies of TATA box-binding protein, TFIIAα, and p300 at both BRF1P4 and GTF3C2P2. These findings indicate that Sp1 controls Pol III-directed transcription and shed light on how Sp1 regulates cancer cell proliferation.
© 2020 Peng et al.

Entities:  

Keywords:  RNA polymerase III; TFIIB-related factor 1 (BRF1); cancer; filamin; filamin A (FLNA); gene transcription; general transcription factor IIIC subunit 2 (GTF3C2); specificity protein 1 (Sp1); transcription

Mesh:

Substances:

Year:  2020        PMID: 32115405      PMCID: PMC7135974          DOI: 10.1074/jbc.RA119.011555

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts.

Authors:  Sara Previdi; Anastasia Malek; Veronica Albertini; Cristina Riva; Carlo Capella; Massimo Broggini; Giuseppina M Carbone; Jurgen Rohr; Carlo V Catapano
Journal:  Gynecol Oncol       Date:  2010-05-08       Impact factor: 5.482

2.  Direct activation of RNA polymerase III transcription by c-Myc.

Authors:  Natividad Gomez-Roman; Carla Grandori; Robert N Eisenman; Robert J White
Journal:  Nature       Date:  2003-01-16       Impact factor: 49.962

3.  Abnormal expression of TFIIIB subunits and RNA Pol III genes is associated with hepatocellular carcinoma.

Authors:  Junxia Lei; Songlin Chen; Shuping Zhong
Journal:  Liver Res       Date:  2017-09-09

4.  Three tRNAs on the ribosome slow translation elongation.

Authors:  Junhong Choi; Joseph D Puglisi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-11       Impact factor: 11.205

Review 5.  Sp1 transcription factor: A long-standing target in cancer chemotherapy.

Authors:  Carolina Vizcaíno; Sylvia Mansilla; José Portugal
Journal:  Pharmacol Ther       Date:  2015-05-08       Impact factor: 12.310

6.  A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.

Authors:  Karita Peltonen; Laureen Colis; Hester Liu; Rishi Trivedi; Michael S Moubarek; Henna M Moore; Baoyan Bai; Michelle A Rudek; Charles J Bieberich; Marikki Laiho
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743

Review 7.  Why should cancer biologists care about tRNAs? tRNA synthesis, mRNA translation and the control of growth.

Authors:  Savraj S Grewal
Journal:  Biochim Biophys Acta       Date:  2014-12-11

Review 8.  RNA polymerase III transcription in cancer: the BRF2 connection.

Authors:  Stephanie Cabarcas; Laura Schramm
Journal:  Mol Cancer       Date:  2011-04-25       Impact factor: 27.401

Review 9.  Transcription by RNA polymerase III: insights into mechanism and regulation.

Authors:  Tomasz W Turowski; David Tollervey
Journal:  Biochem Soc Trans       Date:  2016-10-15       Impact factor: 5.407

10.  Ras/ERK-signalling promotes tRNA synthesis and growth via the RNA polymerase III repressor Maf1 in Drosophila.

Authors:  Shrivani Sriskanthadevan-Pirahas; Rujuta Deshpande; Byoungchun Lee; Savraj S Grewal
Journal:  PLoS Genet       Date:  2018-02-05       Impact factor: 5.917

View more
  4 in total

1.  LncRNA Pnky Positively Regulates Neural Stem Cell Migration by Modulating mRNA Splicing and Export of Target Genes.

Authors:  Jiannan Du; Yuan Li; Yuting Su; Wenqian Zhi; Jiale Zhang; Cheng Zhang; Juan Wang; Wensheng Deng; Shasha Zhao
Journal:  Cell Mol Neurobiol       Date:  2022-06-24       Impact factor: 5.046

2.  Early Growth Response 1 Strengthens Pol-III-Directed Transcription and Transformed Cell Proliferation by Controlling PTEN/AKT Signalling Activity.

Authors:  Zhongyu Wu; Liyun Huang; Shasha Zhao; Juan Wang; Cheng Zhang; Xiaoye Song; Qiyue Chen; Jiannan Du; Deen Yu; Xiaomeng Sun; Yue Zhang; Wensheng Deng; Shihua Zhang; Huan Deng
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

3.  Epigenetic Regulation of TET1-SP1 During Spermatogonia Self-Renewal and Proliferation.

Authors:  Lingling Liu; Jin Wang; Shenghua Wang; Mudi Wang; Yuanhua Chen; Liming Zheng
Journal:  Front Physiol       Date:  2022-02-11       Impact factor: 4.566

4.  PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming.

Authors:  Qianqian Chen; Yiling Wang; Lin Yang; Liyuan Sun; Yuxin Wen; Yongyi Huang; Kaiping Gao; Wenhan Yang; Feng Bai; Lijuan Ling; Zizi Zhou; Xiaoming Zhang; Juan Xiong; Rihong Zhai
Journal:  J Exp Clin Cancer Res       Date:  2022-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.